Telocyte’s gene therapy funded through to clinical trials
Michael Fossel on securing new investment, taking telomerase gene therapy to the clinic, and its potential in cardiovascular disease.
Most Popular
Impact of changes in the epigenome on aging
If changes to the epigenome drive the aging process, might epigenetic manipulation throw things into reverse gear?
A decade of research expands the Hallmarks of Aging from nine to twelve
Aging by the dozen: twelve hallmarks of aging provide comprehensive framework that will be key in the understanding – and delaying – aging.
Researchers identify small molecule that restores visual function after optic nerve injury
Neuroscientists have demonstrate a small molecule that can effectively stimulate nerve regeneration and restore visual function.
New international task force aims to understand the role of aging in Parkinson’s disease
Researchers from 29 institutions, across 11 countries, will join forces in a new network funded by the Michael J Fox Foundation.
Supplements
Buck Institute launches first human clinical trial into ketone body supplementation
First study of ketone body supplementation in healthy older adults will look at ketone ester supplementation in the context of aging.
Editor's pick
Telocyte’s gene therapy funded through to clinical trials
Michael Fossel on securing new investment, taking telomerase gene therapy to the clinic, and its potential in cardiovascular disease.
Longevity investment bulletin: Insilico Medicine, Biophytis, Synartro and more
Longevity investment bulletin featuring news from Insilico Medicine, Biophytis, Synartro, Huma, Hurdle and i-Lumen.
Longevity investment bulletin: Global funding revealed, new SPAC, Recursion, Celularity and more
Longevity investment bulletin, featuring global funding report, new longevity SPAC, Recursion, Celularity, VitaDAO and more.
Global longevity investment hit $5.2 billion in 2022
Our new 2022 annual report shows longevity is out-trending biotech and fintech – and it's not just the Altos effect.
Watch now
The small molecule with a big future
Dr Matthew 'Oki' O'Connor Cyclarity's elegant solution to one of the world's biggest problems – atherosclerosis.
Longitude Prize on dementia names expert judging panel
Turing Institute, University of Cambridge and US longevity experts named judges of ground-breaking dementia tech prize.
Five key steps to getting an AgeTech startup funded
Partner at venture capital firm Flint Capital reveals five key steps to funding success for AgeTech startups.
Aging in place is the “holy grail” of AgeTech
Keren Etkin, author of The AgeTech Revolution, talks aging in place and agetech and how they can benefit society at large.
International Women’s Day: the wonderful women of longevity
Celebrating International Women’s Day, we reflect on just some of the pioneering women we have written about over the last few months.
